As a result of a pipeline shift and other changes intended to extend its cash runway, Sana Biotechnology is laying off employees, the company announced Nov. 4. The Seattle-based company did not specify the number of cuts, when they will occur or which sites are affected. The biotech has locations in Seattle, San Francisco and Cambridge, Massachusetts.
As of Dec. 31, Sana had 328 employees, 251 of whom were involved in research and development activities, according to a February SEC filing.
The layoff news comes roughly a year after Sana downsized its staff by about 120 employees—29%—as it focused resources on its hypoimmune platform. That October 2023 workforce reduction was preceded by layoffs of an unknown number of staff in August 2023.
https://www.biospace.com/job-trends/sana-biotechnology-will-lay-off-employees-as-it-shifts-pipeline